What is the Role of Biologics in UC?

Joanna K. Law; Brian Bressler

doi:10.1002/9781444342574.ch26

What is the Role of Biologics in UC?

Joanna K. Law, Brian Bressler

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.

Original language	English (US)
Title of host publication	Clinical Dilemmas in Inflammatory Bowel Disease
Subtitle of host publication	New Challenges: Second Edition
Publisher	Wiley-Blackwell
Pages	120-123
Number of pages	4
ISBN (Print)	9781444334548
DOIs	https://doi.org/10.1002/9781444342574.ch26
State	Published - Jan 30 2012
Externally published	Yes

Keywords

Biologics
Infliximab
Ulcerative colitis

ASJC Scopus subject areas

General Medicine

Access to Document

10.1002/9781444342574.ch26

Cite this

@inbook{e2b9f32439904c7faec47286709cb656,

title = "What is the Role of Biologics in UC?",

abstract = "The treatment of ulcerative colitis (UC) has traditionally involved 5-aminosalicylates, immunomodulators, and/or corticosteroid therapy along with surgical management. Recent studies have suggested that biologic therapy may have a role in the treatment of ulcerative colitis for patients with moderate to severely active colitis. In this chapter we review the role of biologics in the treatment of UC.",

keywords = "Biologics, Infliximab, Ulcerative colitis",

author = "Law, {Joanna K.} and Brian Bressler",

year = "2012",

month = jan,

day = "30",

doi = "10.1002/9781444342574.ch26",

language = "English (US)",

isbn = "9781444334548",

pages = "120--123",